Liver
metastasis is the predominant cause of
colorectal cancer (CRC)-related mortality in developed countries.
Carcinoembryonic antigen-related cell adhesion molecule 1 (
CEACAM1) is a
cell adhesion molecule with reduced expression in early phases of CRC development and thus functions as a
tumor growth inhibitor. However,
CEACAM1 is upregulated in metastatic
colon cancer, suggesting a bimodal role in CRC progression. To investigate the role of this
protein in the host metastatic environment,
Ceacam1(-/-) mice were injected intrasplenically with metastatic MC38 mouse CRC cells. A significant reduction in metastatic burden was observed in
Ceacam1(-/-) compared with wild-type (WT) livers. Intravital microscopy showed decreased early survival of MC38 cells in
Ceacam1(-/-) endothelial environment. Metastatic cell proliferation within the
Ceacam1(-/-) livers was also diminished. Bone marrow-derived cell recruitment, attenuation of immune infiltrates and diminished CCL2, CCL3 and
CCL5 chemokine production participated in the reduced
Ceacam1(-/-) metastatic phenotype.
Transplantations of WT bone marrow (BM) into
Ceacam1(-/-) mice fully rescued metastatic development, whereas
Ceacam1(-/-) BM transfer into WT mice showed reduced metastatic burden. Chimeric immune cell profiling revealed diminished recruitment of CD11b(+)Gr1(+) myeloid-derived suppressor cells (MDSCs) to
Ceacam1(-/-) metastatic livers and adoptive transfer of MDSCs confirmed the involvement of these immune cells in reduction of liver
metastasis.
CEACAM1 may represent a novel metastatic CRC target for treatment.